High-Frequency Hearing Loss Risk and Your Genetics

Written by Scott Peeples, BS Biomedical Sciences · ExomeDNA Founder Reviewed by ExomeDNA Editorial Process — Editorial Process Last reviewed: 2026-05-25

This page is informational only. For health decisions, consult a qualified clinician.

High-frequency hearing loss is the gradual difficulty perceiving high-pitched sounds — consonants, voices in noisy settings, and upper-register tones — that becomes more common as people age. The ILDR1 gene carries the most consistently replicated genetic signal for this pattern of hearing decline in large population genomic studies. Twin and family research estimates that between 25 and 75 percent of individual variation in age-related hearing ability is heritable. Noise exposure, cardiovascular health, and medication history each play additional roles. Below: the inner ear biology behind high-frequency loss, the key genes, and what current evidence supports.

What is high-frequency hearing loss?

High-frequency hearing loss is difficulty hearing sounds above roughly 2,000 Hz — including consonant sounds, voices in noisy settings, and high-pitched tones. It is the most common pattern of age-related hearing change, progressing gradually and most often beginning with difficulty understanding speech in background noise.

Because most consonant sounds fall in the high-frequency range — "s," "f," "th," "sh" — people with this type of loss often hear that someone is speaking but struggle to make out exactly what was said. This distinction between hearing and understanding is the hallmark complaint. It frequently goes unnoticed for years as people adapt by leaning in, asking for repetition, or raising the television volume before recognizing the change as a hearing issue.

Population genomic studies have identified specific genetic loci that influence how quickly and how early high-frequency hearing ability declines with age, making this trait measurable from genetic data as well as audiometry. (Wells et al. 2019)

The genetics behind high-frequency hearing loss

The most consistently identified common genetic contributor to high-frequency hearing loss is a variant region near the ILDR1 gene — Immunoglobulin-Like Domain Containing Receptor 1 — on chromosome 3. (Wells et al. 2019)

ILDR1 encodes a protein with an immunoglobulin-like domain that is expressed in the inner ear. Based on the gene’s location and expression pattern, the protein appears to contribute to the structural integrity of cochlear sensory cells — the specialized cells of the organ of Corti that convert sound vibrations into electrical signals. The specific molecular mechanism by which common variants near this locus influence age-related high-frequency hearing change remains under active investigation.

It is important to distinguish two different biological contexts associated with ILDR1. Rare, severely damaging mutations in ILDR1 cause DFNB42, a form of autosomal recessive nonsyndromic hearing loss that begins in childhood and can be profound in severity. The common variants near ILDR1 that contribute to age-related high-frequency hearing — the variation captured by ExomeDNA’s assessment — carry far smaller effects, working subtly across decades rather than causing early-onset disease. These are related biological connections but distinct clinical situations.

Other genes in the associated genomic regions include CREB5 (cAMP Response Element Binding Protein 5), which regulates gene expression in response to cellular signaling, and SPIRE2, an actin nucleator involved in cytoskeletal organization. Their specific contributions to age-related high-frequency hearing at the population level appear smaller than ILDR1’s contribution and remain under investigation.

25–75% of individual variation in age-related hearing ability is estimated to be heritable, based on twin and family studies across multiple populations — placing hearing among the more genetically influenced aspects of aging.

ILDR1 is the highest-ranked gene at the most significant genomic locus for high-frequency age-related hearing loss identified in large population genomic studies, with consistent findings across independent cohorts. (Wells et al. 2019)

What the research says

Research base: Moderate. Genome-wide association studies have identified variants near ILDR1 as significantly associated with high-frequency age-related hearing impairment, with replication across independent cohorts. The evidence meets the threshold for a supported genetic association, and the biological context — ILDR1’s expression in the inner ear and its known role in severe monogenic hearing disease — is consistent with a genuine relationship to cochlear function.

The research landscape for frequency-specific hearing loss is relatively recent. Large biobank studies that pair genomic data with audiometry-based hearing assessments have made it possible to separate the genetic architecture of high-frequency from low- and mid-frequency hearing outcomes. Studies have found that these architectures partly differ — some loci associate primarily with high-frequency loss, others with lower-frequency patterns. This separation is why ExomeDNA reports frequency-specific hearing traits rather than a single combined metric. (Wells et al. 2019)

Common genetic variants explain only a portion of total variance in age-related hearing outcomes. Environmental exposures — particularly cumulative noise, cardiovascular health status, and ototoxic medication history — account for substantial additional variation. See our methodology page for the statistical framework underlying this profile.

How high-frequency hearing loss affects you

High-frequency hearing loss typically develops so gradually that people adapt without recognizing the change as a hearing issue. Common early adaptations — moving closer to the speaker, asking others to repeat themselves, raising the television volume, avoiding crowded restaurants — often begin years before anyone frames the difficulty as hearing loss.

The first and most consistent functional effect is difficulty understanding speech in background noise. Background sound masks high-frequency consonants, which carry most of the phonemic information distinguishing words. The cognitive effort required to follow conversation under these conditions is real: prolonged effortful listening is fatiguing and can reduce enjoyment of social situations over time.

Over longer timeframes, untreated hearing difficulty has been associated in observational research with increased social isolation and with faster rates of cognitive decline in aging populations. The mechanisms behind the hearing-cognition relationship are actively studied, and what is consistent across this literature is that proactively addressing hearing change supports broader health in aging.

Environmental and behavioral factors that shape high-frequency hearing

Genetics is one input. Several other factors significantly shape the rate and severity of high-frequency hearing decline:

• Cumulative noise exposure — repeated exposure to sounds above 85 dB causes irreversible cochlear hair cell damage, preferentially at high frequencies; workplace noise and recreational noise (concerts, power tools, extended headphone use at high volume) are major contributors across the lifespan
• Cardiovascular health — the cochlea is highly vascular; hypertension, diabetes, and poor circulation impair cochlear blood flow and are independently associated with accelerated hearing decline
• Ototoxic medications — aminoglycoside antibiotics and platinum-based chemotherapy drugs damage cochlear hair cells; the effect is additive to other risk factors and is dose-dependent
• Smoking — multiple large epidemiological studies link current smoking to higher rates of hearing loss compared to nonsmokers
• Age — biological aging of cochlear hair cells and auditory nerve fibers proceeds independent of specific genetic variants, though the rate differs between individuals

Working with your hearing profile

A genetic signal for elevated susceptibility to high-frequency hearing loss is one input into a multifactorial process — not a determination of what will happen. The following steps are supported by research and directly relevant for anyone with elevated susceptibility or family history of hearing change:

Evidence-backed steps

1. Get a formal baseline hearing assessment. An audiologist can perform frequency-specific audiometry, establishing threshold baselines across the full speech range. Testing in your 40s is reasonable if family history or genetics suggest elevated susceptibility; results give you a personal reference point for future evaluations.
2. Use hearing protection in loud environments. Foam earplugs with NRR 29–33 (approximately 15–17 dB effective reduction in real-world conditions) are effective and inexpensive. Custom-molded musician’s earplugs preserve sound quality for regular use in musical contexts.
3. Apply the 85 dB time-limit guideline. Standard occupational health guidance: 8 hours maximum at 85 dB, with time halved for every 3 dB increase (88 dB = 4 hours, 91 dB = 2 hours). Headphone use at high volume is a growing contributor for younger adults.
4. Prioritize cardiovascular health. Regular aerobic exercise, blood pressure management, and not smoking each show independent associations with better long-term hearing trajectories in large cohort studies.
5. Track hearing over time. Periodic audiometry — every 3–5 years starting in your 40s for people with elevated risk, more frequently if accelerating change is observed — allows earlier detection and earlier intervention.
6. Engage early with hearing support when loss becomes functionally significant. Modern hearing aids are effective across a range of frequency-specific patterns. Earlier fitting is associated with better adaptation, better outcomes, and reduced cognitive effort over time.

Related traits and genes

High-frequency hearing loss shares biological context and genomic neighborhoods with several other traits assessed by ExomeDNA:

• Low-Frequency Hearing Loss Risk — the genetics of low- and mid-frequency hearing decline follow partly distinct pathways, with different loci highlighted; comparing your high- and low-frequency profiles gives a more complete picture of which frequency ranges your genetics most influence
• Tinnitus Susceptibility — ringing or persistent tones in the ears frequently co-occur with hearing loss patterns and may share some biological contributors in the inner ear
• Age-Related Vision Decline — age-related hearing and vision changes share some overlapping longevity biology and are often managed in similar clinical contexts

Cross-category traits with related biology:

• Cardiovascular Disease Risk — vascular health is among the strongest modifiable predictors of cochlear function; your cardiovascular and hearing profiles should be interpreted together
• Cognitive Decline Risk — hearing difficulty and cognitive aging are associated in observational research; proactive management of hearing change may support long-term cognitive health

Frequently asked questions

Is high-frequency hearing loss genetic?

Hearing loss has a meaningful genetic component. Twin studies consistently find that 25 to 75 percent of individual differences in age-related hearing are heritable. Genome-wide studies have linked specific genetic signals — including variants near the ILDR1 gene — to high-frequency hearing decline in particular. Non-genetic factors including noise history, cardiovascular health, and medication exposure also account for substantial variation. A genetic profile here reflects one piece of a multifactorial picture, not a deterministic prediction.

What is the ILDR1 gene and why does it appear on my hearing report?

ILDR1 encodes a protein with an immunoglobulin-like domain that is expressed in the inner ear. It appears to contribute to the structural integrity of cochlear sensory cells. Rare, severely damaging mutations in ILDR1 cause DFNB42, a serious form of childhood-onset hearing loss. Common variants near ILDR1 — found in a meaningful portion of the population — have been separately linked in genomic studies to how high-frequency hearing changes with age. These are related biological contexts but very different clinical scenarios: one rare and severe, the other common and modest in effect.

Will I definitely develop high-frequency hearing loss?

No. A genetic signal for elevated susceptibility is not a certainty. High-frequency hearing decline is very common with age regardless of genotype, and many people with elevated genetic signals maintain good hearing into older age, particularly those who protect their hearing and maintain good cardiovascular health. The genetic profile reflects one input into a process shaped by many factors — including noise history, health behaviors, and lifetime exposures.

How early does high-frequency hearing loss typically begin?

Measurable high-frequency threshold elevation often begins in the third or fourth decade of life, though it typically becomes functionally noticeable in the 50s and 60s. Genetic factors can influence both timing and rate of progression. Occupational or recreational noise exposure — concerts, power tools, extended headphone use — can significantly accelerate the timeline, sometimes causing noticeable loss decades earlier than expected.

Does knowing my genetic risk change what I should do about hearing?

It adds useful context. People with a genetic signal for elevated high-frequency hearing susceptibility have additional reason to prioritize hearing protection, baseline audiometry, and cardiovascular health — steps that are beneficial regardless of genotype but particularly motivated by known susceptibility. The genetic information does not change clinical recommendations or create new medical urgency, but it can support earlier and more consistent preventive action.

Wellness Information. ExomeDNA provides educational interpretation of genetic variants for general wellness purposes only. This does not constitute a clinical evaluation, treatment recommendation, or clinical genetic test. Consult a healthcare provider before making medical decisions. See our methodology and test limitations for details.

References

1. Wells HR, Freidin MB, Zainul Abidin FN, et al. (2019). GWAS identifies 44 independent associated genomic loci for self-reported adult hearing difficulty in UK Biobank. American Journal of Human Genetics, 105(4), 788–802. PMID: 31645637.

Data sources:

• GWAS Catalog (NHGRI-EBI, accessed 2026-05-25)
• Open Targets Platform (CC0 1.0, accessed 2026-05-25)
• ClinVar (NCBI, accessed 2026-05-25) — entries at ≥2-star review status
• ClinGen Gene-Disease Validity (CC0 1.0, accessed 2026-05-25)

This page is published by the ExomeDNA Research Team. Last reviewed: 2026-05-25.